Retraction Note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

Affiliations

¹ The Wistar Institute, Philadelphia, Pennsylvania, USA.
² University of the Sciences, Philadelphia, Pennsylvania, USA.
³ Department of Dermatology, University of Zurich, Zurich, Switzerland.
⁴ The National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
⁵ Department of Dermatology and Pathology, Yale University, New Haven, Connecticut, USA.
⁶ Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston, Massachusetts, USA.
⁷ Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
⁸ Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁹ Department of Medical Oncology, City of Hope Medical Center, Duarte, California, USA.
¹⁰ Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
¹¹ Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
¹² Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
¹³ Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
¹⁴ Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany.
¹⁵ German Cancer Consortium (DKTK), Heidelberg, Germany.
¹⁶ Department of Biochemistry and Molecular Biology, Johns Hopkins School of Medicine, Baltimore, MD, USA. aweeraratna@jhu.edu.

Amanpreet Kaur et al. Nature. 2025 Nov.

. 2025 Nov;647(8089):544.

doi: 10.1038/s41586-025-09719-z.

¹ The Wistar Institute, Philadelphia, Pennsylvania, USA.
² University of the Sciences, Philadelphia, Pennsylvania, USA.
³ Department of Dermatology, University of Zurich, Zurich, Switzerland.
⁴ The National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
⁵ Department of Dermatology and Pathology, Yale University, New Haven, Connecticut, USA.
⁶ Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston, Massachusetts, USA.
⁷ Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
⁸ Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁹ Department of Medical Oncology, City of Hope Medical Center, Duarte, California, USA.
¹⁰ Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California, USA.
¹¹ Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
¹² Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
¹³ Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
¹⁴ Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany.
¹⁵ German Cancer Consortium (DKTK), Heidelberg, Germany.
¹⁶ Department of Biochemistry and Molecular Biology, Johns Hopkins School of Medicine, Baltimore, MD, USA. aweeraratna@jhu.edu.

No abstract available

Retraction of

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH 3rd, Dang VM, Appleton J, O'Connell MP, Cheng P, Valiga AA, Morissette R, McDonnell NB, Ferrucci L, Kossenkov AV, Meeth K, Tang HY, Yin X, Wood WH 3rd, Lehrmann E, Becker KG, Flaherty KT, Frederick DT, Wargo JA, Cooper ZA, Tetzlaff MT, Hudgens C, Aird KM, Zhang R, Xu X, Liu Q, Bartlett E, Karakousis G, Eroglu Z, Lo RS, Chan M, Menzies AM, Long GV, Johnson DB, Sosman J, Schilling B, Schadendorf D, Speicher DW, Bosenberg M, Ribas A, Weeraratna AT. Kaur A, et al. Nature. 2016 Apr 14;532(7598):250-4. doi: 10.1038/nature17392. Epub 2016 Apr 4. Nature. 2016. Retraction in: Nature. 2025 Nov;647(8089):544. doi: 10.1038/s41586-025-09719-z. PMID: 27042933 Free PMC article. Retracted.